BBS-Bioactive Bone Substitutes’ economical calendar and Yearly General Meeting in 2021

Get instant alerts when news breaks on your stocks. Claim your 1-week cost-free demo to


Get instant alerts when news breaks on your stocks. Claim your 1-week cost-free demo to StreetInsider Quality listed here.


For the duration of the year 2021, BBS-Bioactive Bone Substitutes Plc (”BBS”) will publish the monetary information as follows: 

– Fiscal Statements Release for the 12 months 2020    Wed, 24 February 2021  

– 50 %-12 months monetary report January-June 2021        Wed, 25 August 2021        

The Once-a-year Report for the 12 months 2020 will be published on the week 13/2021. 

The Once-a-year Basic Assembly is planned to be held on Wednesday, 28 April 2021. The Board of Administrators of BBS Plc will convene the conference at a later on date.  

BBS-Bioactive Bone Substitutes Plc

Ilkka Kangasniemi, CEO

Far more facts:
Ilkka Kangasniemi, CEO
tel. +358 40 7080 307
e-mail: [email protected]

Distribution:
Nasdaq Helsinki Oy
Nasdaq Stockholm AB
Most important Media
www.bbs-artebone.fi

This is information and facts that BBS-Bioactive Bone Substitutes Plc is obliged to make public pursuant to the EU Market Abuse Regulation. The data was submitted for publication, by the company of the speak to individual set out earlier mentioned on 21 December 2020 at 4:30 pm (UTC+2:00).

BBS – Bioactive Bone Substitutes Ltd

BBS-Bioactive Bone Substitutes Plc is a Finnish orthobiologic biotech company. We have developed a new product or service for therapeutic of tricky bone fractures and for resolving the issues in bone healing. Our mission is to give new technology medicinal solutions for the orthopedic surgical treatment. The study and growth in the discipline of medicine needs perseverance and courage to acquire new things.  We have over 20 yrs of know-how in this. Our operations are characterised by prime know-how, innovativeness and committed and committed staff members. The first merchandise, ARTEBONE® paste, is all set and the application procedure for the CE-marking enabling commercialization is in progress.

Far more information and facts: www.bbs-artebone.fi.

BBS-Bioactive Bone Substitutes Plc shares are detailed on the Nasdaq Very first North Progress Sector Finland and Nasdaq First North Growth Sector Sweden. The company’s Qualified Adviser is Stockholm Accredited Advisers AB, p. +46 70 5516 729, [email protected]